{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T07:30:54Z","timestamp":1768721454632,"version":"3.49.0"},"reference-count":63,"publisher":"American Society of Hematology","issue":"14","license":[{"start":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T00:00:00Z","timestamp":1716854400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,7,23]]},"abstract":"<jats:sec>\n                  <jats:title>Abstract<\/jats:title>\n                  <jats:p>Fibrinolytics delivered into the general circulation lack selectivity for nascent thrombi, reducing efficacy and increasing the risk of bleeding. Urokinase-type plasminogen activator (uPA) transgenically expressed within murine platelets provided targeted thromboprophylaxis without causing bleeding but is not clinically feasible. Recent advances in generating megakaryocytes prompted us to develop a potentially clinically relevant means to produce \u201cantithrombotic\u201d platelets from CD34+ hematopoietic stem cell\u2013derived in vitro\u2013grown megakaryocytes. CD34+ megakaryocytes internalize and store in alpha granules (\u03b1-granules) single-chain uPA (scuPA) and a plasmin-resistant thrombin-activatable variant (uPAT). Both uPAs colocalized with internalized factor V (FV), fibrinogen and plasminogen, low-density lipoprotein receptor\u2013related protein 1 (LRP1), and interferon-induced transmembrane protein 3, but not with endogenous von Willebrand factor (VWF). Endocytosis of uPA by CD34+ megakaryocytes was mediated, in part, via LRP1 and \u03b1IIb\u03b23. scuPA-containing megakaryocytes degraded endocytosed intragranular FV but not endogenous VWF in the presence of internalized plasminogen, whereas uPAT-megakaryocytes did not significantly degrade either protein. We used a carotid artery injury model in nonobese diabetic-severe combined immunodeficiency IL2r\u03b3null (NSG) mice homozygous for VWFR1326H (a mutation switching binding VWF specificity from mouse to human glycoprotein Ib\u03b1) to test whether platelets derived from scuPA- or uPAT-megakaryocytes would prevent thrombus formation. NSG\/VWFR1326H mice exhibited a lower thrombotic burden after carotid artery injury compared with NSG mice unless infused with human platelets or megakaryocytes, whereas intravenous injection of uPA-megakaryocytes generated sufficient uPA-containing human platelets to lyse nascent thrombi. These studies describe the use of in\u00a0vitro\u2013generated megakaryocytes as a potential platform for delivering uPA or other ectopic proteins within platelet \u03b1-granules to sites of vascular injury.<\/jats:p>\n               <\/jats:sec>","DOI":"10.1182\/bloodadvances.2024012835","type":"journal-article","created":{"date-parts":[[2024,5,28]],"date-time":"2024-05-28T18:15:45Z","timestamp":1716920145000},"page":"3798-3809","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":6,"title":["Packaging of supplemented urokinase into alpha granules of in vitro\u2013grown megakaryocytes for targeted nascent clot lysis"],"prefix":"10.1182","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7237-3613","authenticated-orcid":false,"given":"Mortimer","family":"Poncz","sequence":"first","affiliation":[{"name":"1Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"2Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sergei V.","family":"Zaitsev","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hyunsook","family":"Ahn","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M. Anna","family":"Kowalska","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"3Institute of Medical Biology, Polish Academy of Sciences, Lodz, Poland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khalil","family":"Bdeir","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Konstantin V.","family":"Dergilev","sequence":"additional","affiliation":[{"name":"5Institute of Experimental Cardiology, National Medical Research Center of Cardiology named after Academician E.I. Chazov, Moscow, Russia"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3468-8600","authenticated-orcid":false,"given":"Lacramioara","family":"Ivanciu","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"2Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0585-4537","authenticated-orcid":false,"given":"Rodney M.","family":"Camire","sequence":"additional","affiliation":[{"name":"1Department of Pediatrics, Children\u2019s Hospital of Philadelphia, Philadelphia, PA"},{"name":"2Department of Pediatrics, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5986-504X","authenticated-orcid":false,"given":"Douglas B.","family":"Cines","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victoria","family":"Stepanova","sequence":"additional","affiliation":[{"name":"4Department of Pathology and Laboratory Medicine, University of Pennsylvania, Perelman School of Medicine, Philadelphia, PA"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"234","published-online":{"date-parts":[[2024,7,12]]},"reference":[{"issue":"11","key":"2024072313113922000_bib1","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2174\/1389201023666220104143113","article-title":"Fibrinolytic enzyme - an overview","volume":"23","author":"Abdul Rahim","year":"2022","journal-title":"Curr Pharm Biotechnol"},{"key":"2024072313113922000_bib2","doi-asserted-by":"crossref","first-page":"680397","DOI":"10.3389\/fmolb.2021.680397","article-title":"Role of fibrinolytic enzymes in anti-thrombosis therapy","volume":"8","author":"Altaf","year":"2021","journal-title":"Front Mol Biosci"},{"issue":"2","key":"2024072313113922000_bib3","doi-asserted-by":"crossref","first-page":"100081","DOI":"10.1016\/j.rpth.2023.100081","article-title":"Fibrinolysis: an illustrated review","volume":"7","author":"Risman","year":"2023","journal-title":"Res Pract Thromb Haemost"},{"issue":"5","key":"2024072313113922000_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/MBC.0000000000001231","article-title":"Fibrinolytic drugs induced hemorrhage: mechanisms and solutions","volume":"34","author":"Tang","year":"2023","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"5","key":"2024072313113922000_bib5","first-page":"111","article-title":"Practice trends of fibrinogen monitoring in thrombolysis","volume":"7","author":"Kaufman","year":"2018","journal-title":"J\u00a0Clin Med"},{"issue":"5","key":"2024072313113922000_bib6","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1177\/00912700022009125","article-title":"Pharmacokinetics and pharmacodynamics of tenecteplase: results from a phase II study in patients with acute myocardial infarction","volume":"40","author":"Modi","year":"2000","journal-title":"J\u00a0Clin Pharmacol"},{"issue":"11","key":"2024072313113922000_bib7","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1111\/jth.13849","article-title":"Fibrinolysis: from blood to the brain","volume":"15","author":"Medcalf","year":"2017","journal-title":"J\u00a0Thromb Haemost"},{"issue":"5","key":"2024072313113922000_bib8","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1177\/0885066610392658","article-title":"Diagnosis and management of life-threatening pulmonary embolism","volume":"26","author":"Marshall","year":"2011","journal-title":"J\u00a0Intensive Care Med"},{"issue":"4","key":"2024072313113922000_bib9","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1161\/CIRCINTERVENTIONS.111.962316","article-title":"Long-term follow-up of early versus delayed invasive approach after fibrinolysis in acute myocardial infarction","volume":"4","author":"Clever","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"issue":"6","key":"2024072313113922000_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.jcin.2011.01.013","article-title":"Randomized comparison of pre-hospital-initiated facilitated percutaneous coronary intervention versus primary percutaneous coronary intervention in acute myocardial infarction very early after symptom onset: the LIPSIA-STEMI trial (Leipzig immediate prehospital facilitated angioplasty in ST-segment myocardial infarction)","volume":"4","author":"Thiele","year":"2011","journal-title":"JACC Cardiovasc Interv"},{"issue":"2","key":"2024072313113922000_bib11","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1172\/JCI81470","article-title":"A\u00a0chimeric platelet-targeted urokinase prodrug selectively blocks new thrombus formation","volume":"126","author":"Fuentes","year":"2016","journal-title":"J\u00a0Clin Invest"},{"issue":"25","key":"2024072313113922000_bib12","doi-asserted-by":"crossref","first-page":"5241","DOI":"10.1182\/blood-2010-01-261610","article-title":"Sustained thromboprophylaxis mediated by an RBC-targeted pro-urokinase zymogen activated at the site of clot formation","volume":"115","author":"Zaitsev","year":"2010","journal-title":"Blood"},{"issue":"16","key":"2024072313113922000_bib13","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1182\/blood-2017-03-745349","article-title":"Red blood cells in thrombosis","volume":"130","author":"Byrnes","year":"2017","journal-title":"Blood"},{"issue":"3","key":"2024072313113922000_bib14","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1182\/blood-2003-01-0054","article-title":"Antithrombotic thrombocytes: ectopic expression of urokinase-type plasminogen activator in platelets","volume":"102","author":"Kufrin","year":"2003","journal-title":"Blood"},{"issue":"5","key":"2024072313113922000_bib15","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1182\/bloodadvances.2018025429","article-title":"Tranexamic acid is an active site inhibitor of urokinase plasminogen activator","volume":"3","author":"Wu","year":"2019","journal-title":"Blood Adv"},{"issue":"6","key":"2024072313113922000_bib16","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1055\/s-0031-1291382","article-title":"Quebec platelet disorder: update on pathogenesis, diagnosis, and treatment","volume":"37","author":"Blavignac","year":"2011","journal-title":"Semin Thromb Hemost"},{"issue":"7","key":"2024072313113922000_bib17","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.1182\/blood-2008-08-175216","article-title":"Quebec platelet disorder is linked to the urokinase plasminogen activator gene (PLAU) and increases expression of the linked allele in megakaryocytes","volume":"113","author":"Diamandis","year":"2009","journal-title":"Blood"},{"issue":"3","key":"2024072313113922000_bib18","doi-asserted-by":"crossref","first-page":"e0173991","DOI":"10.1371\/journal.pone.0173991","article-title":"The duplication mutation of Quebec platelet disorder dysregulates PLAU, but not C10orf55, selectively increasing production of normal PLAU transcripts by megakaryocytes but not granulocytes","volume":"12","author":"Hayward","year":"2017","journal-title":"PLoS One"},{"issue":"6","key":"2024072313113922000_bib19","first-page":"e01187","article-title":"Management of Quebec platelet disorder for cervical facet injections in the outpatient setting: a case report","volume":"14","author":"Lee","year":"2020","journal-title":"In Pract"},{"issue":"12","key":"2024072313113922000_bib20","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1634\/stemcells.2006-0309","article-title":"Ex\u00a0vivo large-scale generation of human platelets from cord blood CD34+ cells","volume":"24","author":"Matsunaga","year":"2006","journal-title":"Stem Cell"},{"issue":"4","key":"2024072313113922000_bib21","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/j.bbrc.2008.11.117","article-title":"Generation of megakaryocytes and platelets from human subcutaneous adipose tissues","volume":"378","author":"Matsubara","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"issue":"5","key":"2024072313113922000_bib22","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1182\/blood-2013-10-530725","article-title":"High-level transgene expression in induced pluripotent stem cell-derived megakaryocytes: correction of Glanzmann thrombasthenia","volume":"123","author":"Sullivan","year":"2014","journal-title":"Blood"},{"issue":"22","key":"2024072313113922000_bib23","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1182\/blood.2022017296","article-title":"iPLAT1: the first-in-human clinical trial of iPSC-derived platelets as a phase 1 autologous transfusion study","volume":"140","author":"Sugimoto","year":"2022","journal-title":"Blood"},{"issue":"2","key":"2024072313113922000_bib63","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/term.2785","article-title":"Packaging functionally important plasma proteins into the \u03b1-granules of human-induced pluripotent stem cell-derived megakaryocytes","volume":"13","author":"Zhang","year":"2019","journal-title":"J Tissue Eng Regen Med"},{"issue":"6","key":"2024072313113922000_bib24","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1182\/bloodadvances.2017010975","article-title":"Enhancing functional platelet release in\u00a0vivo from in\u00a0vitro-grown megakaryocytes using small molecule inhibitors","volume":"2","author":"Jarocha","year":"2018","journal-title":"Blood Adv"},{"issue":"3","key":"2024072313113922000_bib25","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1182\/blood-2004-03-0995","article-title":"Regulation of the single-chain urokinase-urokinase receptor complex activity by plasminogen and fibrin: novel mechanism of fibrin specificity","volume":"105","author":"Higazi","year":"2005","journal-title":"Blood"},{"issue":"26","key":"2024072313113922000_bib26","doi-asserted-by":"crossref","first-page":"23044","DOI":"10.1074\/jbc.M110.210195","article-title":"Urokinase-type plasminogen activator (uPA) induces pulmonary microvascular endothelial permeability through low density lipoprotein receptor-related protein (LRP)-dependent activation of endothelial nitric-oxide synthase","volume":"286","author":"Makarova","year":"2011","journal-title":"J\u00a0Biol Chem"},{"issue":"1","key":"2024072313113922000_bib27","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1055\/s-0038-1642694","article-title":"New antiplatelet agents: platelet GPIIb\/IIIa antagonists","volume":"74","author":"Coller","year":"1995","journal-title":"Thromb Haemost"},{"key":"2024072313113922000_bib28","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1161\/hc3301.094533","article-title":"Abciximab readminstration: results of the ReoPro Readministration Registry","volume":"104(8)","author":"Tcheng","year":"2001","journal-title":"Circulation"},{"issue":"1","key":"2024072313113922000_bib29","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41467-019-13928-2","article-title":"Structure-guided design of pure orthosteric inhibitors of alphaIIbbeta3 that prevent thrombosis but preserve hemostasis","volume":"11","author":"Adair","year":"2020","journal-title":"Nat Commun"},{"issue":"3","key":"2024072313113922000_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1182\/blood.2022017561","article-title":"RUNX1-deficient human megakaryocytes demonstrate thrombopoietic and platelet half-life and functional defects","volume":"141","author":"Lee","year":"2023","journal-title":"Blood"},{"issue":"4","key":"2024072313113922000_bib31","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1172\/JCI114300","article-title":"Uptake of plasma fibrinogen into the alpha granules of human megakaryocytes and platelets","volume":"84","author":"Harrison","year":"1989","journal-title":"J\u00a0Clin Invest"},{"issue":"suppl 1","key":"2024072313113922000_bib32","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1182\/blood-2019-124788","article-title":"A\u00a0novel approach for generating platelet-delivered FVIII: role of transient LRP1 expression during megakaryopoiesis","volume":"134","author":"Tkaczynski","year":"2019","journal-title":"Blood"},{"issue":"3","key":"2024072313113922000_bib33","first-page":"143","article-title":"Urokinase\/urokinase receptor system: internalization\/degradation of urokinase-serpin complexes: mechanism and regulation","volume":"376","author":"Conese","year":"1995","journal-title":"Biol Chem Hoppe Seyler"},{"issue":"2","key":"2024072313113922000_bib34","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/MBC.0b013e3282f41e3e","article-title":"Quebec platelet disorder: features, pathogenesis and treatment","volume":"19","author":"Diamandis","year":"2008","journal-title":"Blood Coagul Fibrinolysis"},{"issue":"1","key":"2024072313113922000_bib56","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1182\/blood-2007-07-104455","article-title":"Nuclear translocation of urokinase-type plasminogen activator","volume":"112","author":"Stepanova","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2024072313113922000_bib57","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1189\/jlb.0305158","article-title":"The kringle domain of urokinase-type plasminogen activator potentiates LPS-induced neutrophil activation through interaction with {alpha}V{beta}3 integrins","volume":"78","author":"Kwak","year":"2005","journal-title":"J\u00a0Leukoc Biol"},{"issue":"3","key":"2024072313113922000_bib58","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1160\/TH05-06-0457","article-title":"Direct interaction of the kringle domain of urokinase-type plasminogen activator (uPA) and integrin alpha v beta 3 induces signal transduction and enhances plasminogen activation","volume":"95","author":"Tarui","year":"2006","journal-title":"Thromb Haemost"},{"issue":"9","key":"2024072313113922000_bib59","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1515\/CCLM.1998.123","article-title":"The cleavage of pro-urokinase type plasminogen activator by stromelysin-1","volume":"36","author":"Orgel","year":"1998","journal-title":"Clin Chem Lab Med"},{"issue":"4","key":"2024072313113922000_bib48","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1182\/blood-2007-07-103002","article-title":"Prophylactic thrombolysis by thrombin-activated latent prourokinase targeted to PECAM-1 in the pulmonary vasculature","volume":"111","author":"Ding","year":"2008","journal-title":"Blood"},{"issue":"4","key":"2024072313113922000_bib35","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/j.1538-7836.2008.02894.x","article-title":"A\u00a0unique function for LRP-1: a component of a two-receptor system mediating specific endocytosis of plasma-derived factor V by megakaryocytes","volume":"6","author":"Bouchard","year":"2008","journal-title":"J\u00a0Thromb Haemost"},{"issue":"11","key":"2024072313113922000_bib36","doi-asserted-by":"crossref","first-page":"2290","DOI":"10.1182\/blood-2009-04-216473","article-title":"Platelet factor 4 regulates megakaryopoiesis through low-density lipoprotein receptor-related protein 1 (LRP1) on megakaryocytes","volume":"114","author":"Lambert","year":"2009","journal-title":"Blood"},{"key":"2024072313113922000_bib60","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.intimp.2019.01.036","article-title":"LRP1 receptor-mediated immunosuppression of alpha-MMC on monocytes","volume":"70","author":"Deng","year":"2019","journal-title":"Int Immunopharmacol"},{"issue":"1","key":"2024072313113922000_bib37","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1182\/blood.V82.1.135.bloodjournal821135","article-title":"Endocytosis of fibrinogen into megakaryocyte and platelet\u00a0alpha-granules is mediated by alpha IIb beta 3 (glycoprotein IIb-IIIa)","volume":"82","author":"Handagama","year":"1993","journal-title":"Blood"},{"issue":"5","key":"2024072313113922000_bib38","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1091\/mbc.12.5.1467","article-title":"Direct binding of occupied urokinase receptor (uPAR) to LDL receptor-related protein is required for endocytosis of uPAR and regulation of cell surface urokinase activity","volume":"12","author":"Czekay","year":"2001","journal-title":"Mol Biol Cell"},{"issue":"23","key":"2024072313113922000_bib39","doi-asserted-by":"crossref","first-page":"e153014","DOI":"10.1172\/JCI153014","article-title":"IFITM3 regulates fibrinogen endocytosis and platelet reactivity in nonviral sepsis","volume":"132","author":"Campbell","year":"2022","journal-title":"J\u00a0Clin Invest"},{"issue":"8","key":"2024072313113922000_bib40","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1182\/blood-2006-03-009449","article-title":"Impaired megakaryocytopoiesis in type 2B von Willebrand disease with severe thrombocytopenia","volume":"108","author":"Nurden","year":"2006","journal-title":"Blood"},{"issue":"1","key":"2024072313113922000_bib41","doi-asserted-by":"crossref","first-page":"4026","DOI":"10.1038\/s41467-023-39598-9","article-title":"Highly efficient platelet generation in lung vasculature reproduced by microfluidics","volume":"14","author":"Zhao","year":"2023","journal-title":"Nat Commun"},{"issue":"23","key":"2024072313113922000_bib61","doi-asserted-by":"crossref","first-page":"3627","DOI":"10.1182\/blood-2014-08-593053","article-title":"Comparative analysis of human ex\u00a0vivo-generated platelets vs megakaryocyte-generated platelets in mice: a cautionary tale","volume":"125","author":"Wang","year":"2015","journal-title":"Blood"},{"issue":"23","key":"2024072313113922000_bib62","doi-asserted-by":"crossref","first-page":"5021","DOI":"10.1182\/blood-2010-03-276964","article-title":"Monocyte-bound PF4 in the pathogenesis of heparin-induced thrombocytopenia","volume":"116","author":"Rauova","year":"2010","journal-title":"Blood"},{"issue":"23","key":"2024072313113922000_bib42","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1182\/bloodadvances.2022008512","article-title":"Production and nonclinical evaluation of an autologous iPSC-derived platelet product for the iPLAT1 clinical trial","volume":"6","author":"Sugimoto","year":"2022","journal-title":"Blood Adv"},{"issue":"4","key":"2024072313113922000_bib43","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.stem.2014.01.011","article-title":"Expandable megakaryocyte cell lines enable clinically applicable generation of platelets from human induced pluripotent stem cells","volume":"14","author":"Nakamura","year":"2014","journal-title":"Cell Stem Cell"},{"issue":"19","key":"2024072313113922000_bib44","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.2174\/138161211796718206","article-title":"The urokinase receptor in hematopoietic stem cells mobilization","volume":"17","author":"Blasi","year":"2011","journal-title":"Curr Pharm Des"},{"issue":"2","key":"2024072313113922000_bib45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/j.1460-2075.1990.tb08132.x","article-title":"Cloning and expression of the receptor for human urokinase plasminogen activator, a central molecule in cell surface, plasmin dependent proteolysis","volume":"9","author":"Roldan","year":"1990","journal-title":"EMBO J"},{"issue":"6","key":"2024072313113922000_bib46","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1165\/rcmb.2009-0257OC","article-title":"Regulation of airway contractility by plasminogen activators through N-methyl-D-aspartate receptor-1","volume":"43","author":"Nassar","year":"2010","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"5","key":"2024072313113922000_bib47","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1165\/rcmb.2010-0302OC","article-title":"Urokinase plasminogen activator regulates pulmonary arterial contractility and vascular permeability in mice","volume":"45","author":"Nassar","year":"2011","journal-title":"Am J Respir Cell Mol Biol"},{"issue":"9","key":"2024072313113922000_bib49","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1158\/1535-7163.MCT-16-0710","article-title":"Inhibition of megakaryocyte differentiation by antibody-drug conjugates (ADCs) is mediated by macropinocytosis: implications for ADC-induced thrombocytopenia","volume":"16","author":"Zhao","year":"2017","journal-title":"Mol Cancer Ther"},{"issue":"3","key":"2024072313113922000_bib50","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s00418-022-02124-x","article-title":"Megapinosomes and homologous structures in hematopoietic cells","volume":"158","author":"Bauer","year":"2022","journal-title":"Histochem Cell Biol"},{"issue":"5","key":"2024072313113922000_bib51","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/j.1538-7836.2006.01877.x","article-title":"Insights into abnormal hemostasis in the Quebec platelet disorder from analyses of clot lysis","volume":"4","author":"Diamandis","year":"2006","journal-title":"J\u00a0Thromb Haemost"},{"issue":"9","key":"2024072313113922000_bib52","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1182\/bloodadvances.2017007914","article-title":"Infused factor VIII-expressing platelets or megakaryocytes as a novel therapeutic strategy for hemophilia A","volume":"3","author":"Lyde","year":"2019","journal-title":"Blood Adv"},{"issue":"12","key":"2024072313113922000_bib53","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1182\/blood-2003-05-1519","article-title":"Factor VIII ectopically expressed in platelets: efficacy in hemophilia A treatment","volume":"102","author":"Yarovoi","year":"2003","journal-title":"Blood"},{"issue":"21","key":"2024072313113922000_bib54","doi-asserted-by":"crossref","first-page":"3326","DOI":"10.1182\/blood-2014-07-587139","article-title":"Platelet-delivered ADAMTS13 inhibits arterial thrombosis and prevents thrombotic thrombocytopenic purpura in murine models","volume":"125","author":"Pickens","year":"2015","journal-title":"Blood"},{"issue":"11","key":"2024072313113922000_bib55","doi-asserted-by":"crossref","first-page":"2731","DOI":"10.1161\/ATVBAHA.118.311407","article-title":"Transfusion of platelets loaded with recombinant ADAMTS13 (a disintegrin and metalloprotease with thrombospondin type 1 repeats-13) is efficacious for inhibiting arterial thrombosis associated with thrombotic thrombocytopenic purpura","volume":"38","author":"Abdelgawwad","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/14\/3798\/2235680\/blooda_adv-2024-012835-main.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article-pdf\/8\/14\/3798\/2235680\/blooda_adv-2024-012835-main.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T13:43:10Z","timestamp":1721742190000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/8\/14\/3798\/516230\/Packaging-of-supplemented-urokinase-into-alpha"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,7,12]]},"references-count":63,"journal-issue":{"issue":"14","published-print":{"date-parts":[[2024,7,23]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2024012835","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,7,12]]}}}